NAS:SMTI (USA)
Sanara MedTech Inc $ 33.98 0 (0%)
Volume:
0
Avg Vol (1m):
46,203
Market Cap $:
257.86 Mil
Enterprise Value $:
256.54 Mil
PE Ratio:
0.00
PB Ratio:
36.19
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.94 | ||
| Equity-to-Asset | 0.61 | ||
| Debt-to-Equity | 0.19 | ||
| Debt-to-EBITDA | -0.2 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 36.68 | ||
| Beneish M-Score | -2.08 | ||
| WACC vs ROIC | |||
Profitability Rank | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -39.34 | ||
| Net Margin % | -39.39 | ||
| ROE % | -120.26 | ||
| ROA % | -62.34 | ||
| ROC (Joel Greenblatt) % | -598.49 | ||
| 3-Year Revenue Growth Rate | 2.8 | ||
| 3-Year EBITDA Growth Rate | -94.6 | ||
| 3-Year EPS without NRI Growth Rate | -9.7 |
SMTI
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 36.19 | ||
| PS Ratio | 11.92 | ||
| EV-to-EBIT | -45.64 | ||
| EV-to-EBITDA | -47.84 | ||
| EV-to-Revenue | 18.13 | ||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.45 | ||
| Days Inventory | 215.21 | ||
| Days Sales Outstanding | 46.22 | ||
| Days Payable | 94.38 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -48.2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 79.02 | ||
| Price-to-Median-PS-Value | 5 | ||
| Earnings Yield (Greenblatt) % | -2.19 |